Molecular mechanisms and therapeutic effects of (-)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Shay, Joseph ^a,b   Elbaz, Hosam A ^a,c   Lee, Icksoo ^d   Zielske, Steven P ^c   Malek, Moh H ^c   Hüttemann, Maik ^a,b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CELL SIGNALING; CHEMOTHERAPY; FLAVONOIDS; NEURODEGENERATIVE DISEASES; RADIOTHERAPY;

BIOLOGICAL EFFECTS; CARDIO-VASCULAR DISEASE; EPIGALLOCATECHIN GALLATE; MOLECULAR MECHANISM; NATURAL COMPOUNDS; PHENOLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; THERAPEUTIC EFFECTS;

DISEASES;

APIGENIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; CATECHIN; POLYPHENOL;

BIOLOGICAL FUNCTIONS; CELL PROLIFERATION; DIABETES MELLITUS; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NONHUMAN; OXIDATION; REPERFUSION INJURY; REVIEW; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; METABOLISM; MITOCHONDRION; NEOPLASMS; NEURODEGENERATIVE DISEASES; PATHOLOGY; SIGNAL TRANSDUCTION;

CATECHIN; HUMANS; INFLAMMATION; MITOCHONDRIA; NEOPLASMS; NEURODEGENERATIVE DISEASES; POLYPHENOLS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84934892145     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/181260     Document Type: Review

References (107)

1. K. B. Pandey and S. I. Rizvi, "Plant polyphenols as dietary antioxidants in human health and disease, " Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270-278, 2009.
2. A. Scalbert, I. T. Johnson, and M. Saltmarsh, "Polyphenols: Antioxidants and beyond, " The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 215S-217S, 2005.
3. D. R. Galasko, E. Peskind, C. M. Clark et al., "Antioxidants for Alzheimer disease: A r and omized clinical trial with cerebrospinal fluid biomarkermeasures, " Archives of Neurology, vol. 69, no. 7, pp. 836-841, 2012.
4. D. Mekinová, V. Chorváthová, K. Volkovová et al., "Effect of intake of exogenous vitamins C, E and beta-carotene on the antioxidative status in kidneys of rats with streptozotocininduced diabetes, " Die Nahrung, vol. 39, no. 4, pp. 257-261, 1995.
5. A. P. Dare and R. P. Hellens, "RNAinterference silencing ofCHS greatly alters the growth pattern of apple (Malus x domestica), " Plant Signaling and Behavior, vol. 8, no. 8, 2013.
6. B. N. Singh, S. Shankar, and R. K. Srivastava, "Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications, " Biochemical Pharmacology, vol. 82, no. 12, pp. 1807-1821, 2011.
7. C. H. Lin, L. K. Chao, P. H. Hung, and Y. J. Chen, "EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 5, pp. 2372-2381, 2014.
8. S. Mukherjee, M. A. Siddiqui, S. Dayal, Y. Z. Ayoub, and K. Malathi, "Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells, " Journal of Inflammation Research, vol. 7, pp. 89-101, 2014.
9. T. Poutahidis, K. Cappelle, T. Levkovich et al., "Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice, " PLoS ONE, vol. 8, no. 8, Article ID e73933, 2013.
10. H. Q. Luo, M. Xu, W. T. Zhong et al., "EGCG decreases the expression of HIF-1 and VEGF and cell growth in MCF-7 breast cancer cells, " Journal of B.U.ON., vol. 19, no. 2, pp. 435-439, 2014.
11. W. Zhu, J. Xu, Y. Ge et al., "Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression, " Journal of Radiation Research, vol. 55, no. 6, pp. 1056-1065, 2014.
12. S. A. M and el, T. Amit, L. Kalfon, L. Reznichenko, O. Weinreb, and M. B. H. Youdim, "Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG), " Journal of Alzheimers Disease, vol. 15, no. 2, pp. 211-222, 2008.
13. J. Bieschke, J. Russ, R. P. Friedrich et al., "EGCG remodels mature-synuclein and amyloid-fibrils and reduces cellular toxicity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 17, pp. 7710-7715, 2010.
14. F. Meng, A. Abedini, A. Plesner, C. B. Verchere, and D. P. Raleigh, "The Flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPPinduced toxicity, " Biochemistry, vol. 49, no. 37, pp. 8127-8133, 2010.
15. Y. Porat, A. Abramowitz, and E. Gazit, "Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism, " Chemical Biology and DrugDesign, vol. 67, no. 1, pp. 27-37, 2006.
16. N. Ferreira, M. J. Saraiva, and M. R. Almeida, "Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: in vivo evidence from FAP mice models, " PLoS ONE, vol. 7, no. 1, Article IDe29933, 2012.
17. T. Zhang, J. Zhang, P. Derreumaux, and Y. Mu, "Molecular mechanism of the inhibition of EGCG on the Alzheimer Abeta(1-42) dimer, " Journal of Physical Chemistry B, vol. 117, no. 15, pp. 3993-4002, 2013.
18. R. A. Dixon and D. Ferreira, "Genistein, " Phytochemistry, vol. 60, no. 3, pp. 205-211, 2002.
19. F.-P. Chen and M.-H. Chien, "Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro, " Climacteric, vol. 17, no. 6, pp. 682-691, 2014.
20. I. E. Obiorah, P. Fan, and V. C. O. Jordan, "Breast cancer cell apoptosis with phytoestrogens is dependent on an estrogendeprived state, " Cancer Prevention Research, vol. 7, no. 9, pp. 939-949, 2014.
21. M. Gętek, , N. Czech, M. Muc-Wierzgoń, E. Grochowska-Niedworok, T. Kokot, and E. Nowakowska-Zajdel, "The active role of leguminous plant components in type 2 diabetes, " Evidence-based Complementary and Alternative Medicine, vol. 2014, Article ID293961, 12 pages, 2014.
22. S. C. Manolagas, "Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis, " Endocrine Reviews, vol. 21, no. 2, pp. 115-137, 2000.
23. M. A. Espel and , P. E. Hogan, S. E. Flneberg et al., "Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/ Progestin Interventions, " Diabetes Care, vol. 21, no. 10, pp. 1589-1595, 1998.
24. T. L. Guo, D. R. Germolec, J. F. Zheng et al., "Genistein protects female nonobese diabetic mice from developing type 1 diabetes when fed a soy-And alfalfa-free diet, " Toxicologic Pathology, 2014.
25. X. Shao, H. Chen, Y. Zhu, R. Sedighi, C.-T. Ho, and S. Sang, "Essential structural requirements and additive effects for flavonoids to scavenge methylglyoxal, " Journal of Agricultural and Food Chemistry, vol. 62, no. 14, pp. 3202-3210, 2014.
26. F. Squadrito, H. Marini, A. Bitto et al., "Genistein in the metabolic syndrome: results of a r and omized clinical trial, " The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 8, pp. 3366-3374, 2013.
27. K. H. Miean and S. Mohamed, "Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants, " Journal of Agricultural and FoodChemistry, vol. 49, no. 6, pp. 3106-3112, 2001.
28. W. Wang, L. Heideman, C. S. Chung, J. C. Pelling, K. J. Koehler, and D. F. Birt, "Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines, " Molecular Carcinogenesis, vol. 28, no. 2, pp. 102-110, 2000.
29. M. E. Harrison, M. R. Power-Coombs, L. M. Delaney, and D. W. Hoskin, "Exposure of breast cancer cells to a subcytotoxic dose of apigenin causes growth inhibition, oxidative stress, and hypophosphorylation of Akt, " Experimental and Molecular Pathology, vol. 97, no. 2, pp. 211-217, 2014.
30. M. Warat, E. Szliszka, I. Korzonek-Szlacheta, W. Król, and Z. P. Czuba, "Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing lig and receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages, " International Journal of Molecular Sciences, vol. 15, no. 7, pp. 11510-11522, 2014.
31. M.L. McCullough, K. Chevaux, L. Jacksonet al., "Hypertension, the Kuna, and the epidemiology of flavanols, " Journal of Cardiovascular Pharmacology, vol. 47, no. 2, pp. S103-S109, 2006.
32. R. Corti, A. J. Flammer, N. K. Hollenberg, and T. F. Luscher, "Cocoa and cardiovascular health, " Circulation, vol. 119, no. 10, pp. 1433-1441, 2009.
33. A. Belščak, D. Komes, D. Horžić, K. K. Ganić, and D. Karlović, "Comparative study of commercially available cocoa products in terms of their bioactive composition, " Food Research International, vol. 42, no. 5-6, pp. 707-716, 2009.
34. M. B. Engler, M. M. Engler, C. Y. Chen et al., "Flavonoidrich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults, " Journal of the American College of Nutrition, vol. 23, no. 3, pp. 197-204, 2004.
35. M. Devgun, A. N and a, and S. H. Ansari, "Pterocarpus marsupium Roxb.-A comprehensive review, " Pharmacognosy Reviews, vol. 3, no. 6, pp. 359-363, 2009.
36. E.W. Sheehan, M. A. Zemaitis, D. J. Slatkin, and P. L. Schiff Jr., "A constituent of Pterocarpus marsupium, (-)-epicatechin, as a potential antidiabetic agent, " Journal of Natural Products, vol. 46, no. 2, pp. 232-234, 1983.
37. F. Ahmad, P. Khalid, M. M. Khan, A. K. Rastogi, and J. R. Kidwai, "Insulin like activity in (-) epicatechin, " Acta Diabetologica Latina, vol. 26, no. 4, pp. 291-300, 1989.
38. C. G. Fraga and P. I. Oteiza, "Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling, " Free Radical Biology and Medicine, vol. 51, no. 4, pp. 813-823, 2011.
39. D. Rein, S. Lotito, R. R. Holt, C. L. Keen, H. H. Schmitz, and C. G. Fraga, "Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status, " The Journal of Nutrition, vol. 130, no. 8, pp. 2109S-2114S, 2000.
40. A. J. Jung, J. J. Mee, Y. K. Ji, Y. C. Hae, and S. C. Jae, "Inhibitory activity of flavonoids from Prunus davidiana and other flavonoids on total ROS and hydroxyl radical generation, " Archives of Pharmacal Research, vol. 26, no. 10, pp. 809-815, 2003.
41. E. J. B. Ruijters, A. R. Weseler, C. Kicken, G. R. M. M. Haenen, and A. Bast, "The flavanol (-)-epicatechin and its metabolites protect against oxidative stress in primary endothelial cells via a direct antioxidant effect, " European Journal of Pharmacology, vol. 715, no. 1-3, pp. 147-153, 2013.
42. N. Dickerhof, N. J. Magon, J. D. Tyndall, A. J. Kettle, and M. B. Hampton, "Potent inhibition of macrophage migration inhibitory factor (MIF) by myeloperoxidase-dependent oxidation of epicatechins, " Biochemical Journal, vol. 462, no. 2, pp. 303-314, 2014.
43. M.-J. Kim, G. R. Ryu, J.-H. Kang et al., "Inhibitory effects of epicatechin on interleukin-1-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-B activation, " Biochemical Pharmacology, vol. 68, no. 9, pp. 1775-1785, 2004.
44. H. Goldenstein, N. S. Levy, Y. T. Lipener, and A. P. Levy, "Patient selection and vitamin E treatment in diabetes mellitus, " Expert Review of Cardiovascular Therapy, vol. 11, no. 3, pp. 319-326, 2013.
45. A.-H. Harding, N. J. Wareham, S. A. Bingham et al., "Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitusTheEuropean prospective investigation of cancer-Norfolk prospective study, " Archives of Internal Medicine, vol. 168, no. 14, pp. 1493-1499, 2008.
46. G. N. Dakhale, H. V. Chaudhari, and M. Shrivastava, "Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: A r and omized, double-blind study, " Advances in Pharmacological Sciences, vol. 2011, Article ID 195271, 5 pages, 2011.
47. M. Morrison, R. van derHeijden, P. Heeringa et al., "Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFB in vivo, " Atherosclerosis, vol. 233, no. 1, pp. 149-156, 2014.
48. P. C. D. P. Vasconcelos, L. N. Seito, L. C. di Stasi, C. Akiko Hiruma-Lima, and C. H. Pellizzon, "Epicatechin used in the treatment of intestinal inflammatory disease: An analysis by experimental models, " Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 508902, 12 pages, 2012.
49. S. Shukla, H. Shukla, S. Kumar, R. P. Aharwal, V. K. Gupta, and S. S. S and hu, "Allergy and inflammation: An immunological and therapeutic approach, " Recent Patents on Inflammation and Allergy Drug Discovery, vol. 7, no. 2, pp. 135-150, 2013.
50. A. Singh, A. Demont, L. Actis-Goretta et al., "Identification of epicatechin as one of the key bioactive constituents of polyphenol-enriched extracts that demonstrate an anti-Allergic effect in a murine model of food allergy, " British Journal of Nutrition, vol. 112, no. 3, pp. 358-368, 2014.
51. J. Ognjenović, M. Stojadinović, M. Milčić et al., "Interactions of epigallo-catechin 3-gallate and ovalbumin, themajor allergen of egg white, " Food Chemistry, vol. 164, pp. 36-43, 2014.
52. N. B. Janakiram and C. V. Rao, "The role of inflammation in colon cancer, " in Inflammation and Cancer, vol. 816 of Advances in Experimental Medicine and Biology, pp. 25-52, Springer, Basel, Switzerl and , 2014.
53. C. S. D. Roxburgh and D. C. McMillan, "Cancer and systemic inflammation: treat the tumour and treat the host, " British Journal of Cancer, vol. 110, no. 6, pp. 1409-1412, 2014.
54. M.A. Papiez, J. Baran, K. Bukowska-Straková, and W. Wiczkowski, "Antileukemic action of (-)-epicatechin in the spleen of rats with acute myeloid leukemia, " Food and Chemical Toxicology, vol. 48, no. 12, pp. 3391-3397, 2010.
55. G. G. Mackenzie and P. I. Oteiza, "Modulation of transcription factor NF-B in Hodgkins lymphoma cell lines: effect of (-)-epicatechin, " Free Radical Research, vol. 40, no. 10, pp. 1086-1094, 2006.
56. E. Matteucci, S. I. Rizvi, and O. Giampietro, "Erythrocyte sodium/hydrogen exchange inhibition by (-) epicatechin, " Cell Biology International, vol. 25, no. 8, pp. 771-776, 2001.
57. S. I. Rizvi and M. A. Zaid, "Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins, " Clinica Chimica Acta, vol. 354, no. 1-2, pp. 59-67, 2005.
58. Y.-H. Lee, J. Kwak, H.-K. Choi et al., "EGCGsuppresses prostate cancer cell growth modulating acetylation of and rogen receptor by anti-histone acetyltransferase activity, " International Journal of Molecular Medicine, vol. 30, no. 1, pp. 69-74, 2012.
59. H. R. Siddique, D. J. Liao, S. K. Mishra et al., "Epicatechin-rich cocoa polyphenol inhibits Kras-Activated pancreatic ductal carcinomacell growth in vitro and in amousemodel, " International Journal of Cancer, vol. 131, no. 7, pp. 1720-1731, 2012.
60. C. D. Varghese, S. C. Nair, B. Panikkar, and K. R. Panikkar, "Effect of asoka on the intracellular glutathione levels and skin tumour promotion in mice, " Cancer Letters, vol. 69, no. 1, pp. 45-50, 1993.
61. M. Rodriguez, G.-J. Du, C.-Z. Wang, and C.-S. Yuan, "Letter to the editor: panaxadiols anticancer activity is enhanced by epicatechin, " The American Journal of ChineseMedicine, vol. 38, no. 6, pp. 1233-1235, 2010.
62. J. S. Lee, S. U. Kang, H. S. Hwang, J. H. Pyun, Y. H. Choung, and C. H. Kim, "Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK, " Toxicology Letters, vol. 199, no. 3, pp. 308-316, 2010.
63. H. A. Shin, Y. S. Shin, S. U. Kang et al., "Radioprotective effect of epicatechin in cultured human fibroblasts and zebrafish, " Journal of Radiation Research, vol. 55, no. 1, pp. 32-40, 2014.
64. Y. S. Shin, H. A. Shin, S. U. Kang et al., "Effect of epicatechin against radiation-induced oral mucositis: in vitro and in vivo study, " PLoS ONE, vol. 8, no. 7, Article ID e69151, 2013.
65. S. Basu-Modak, M. J. Gordon, L.H. Dobson, J. P. E. Spencer, C. Rice-Evans, and R. M. Tyrrell, "Epicatechin and itsmethylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts, " Free Radical Biology and Medicine, vol. 35, no. 8, pp. 910-921, 2003.
66. R. H. Mohamed, R. A. Karam, and M. G. Amer, "Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-, iNOS and NF-B, " Brain Research Bulletin, vol. 86, no. 1-2, pp. 22-28, 2011.
67. K. Tanabe, Y. Tamura, M. A. Lanaspa et al., "Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy, "AmericanJournal of Physiology:Renal Physiology, vol. 303, no. 9, pp. F1264-F1274, 2012.
68. C.-H. Kim, S. U. Kang, J. Pyun, M. H. Lee, H. S. Hwang, and H. Lee, "Epicatechin protects auditory cells against cisplatininduced death, " Apoptosis, vol. 13, no. 9, pp. 1184-1194, 2008.
69. H. A. Elbaz, I. Lee, D. A. Antwih, J. Liu, M. Hüttemann, and S. P. Zielske, "Epicatechin stimulates mitochondrial activity and selectively sensitizes cancer cells to radiation, " PLoS ONE, vol. 9, no. 2, Article ID e88322, 2014.
70. K. D. Robertson, "DNA methylation, methyltransferases, and cancer, " Oncogene, vol. 20, no. 24, pp. 3139-3155, 2001.
71. L. Delgado, I. Fern and es, S. González-Manzano, V. De Freitas, N. Mateus, and C. Santos-Buelga, "Anti-proliferative effects of quercetin and catechin metabolites, " Food and Function, vol. 5, no. 4, pp. 797-803, 2014.
72. M. Wang, Z. Xu, L. Chen, H. Yin, and S. Ai, "Electrochemical immunosensing platform for DNA methyltransferase activity analysis and inhibitor screening, " Analytical Chemistry, vol. 84, no. 21, pp. 9072-9078, 2012.
73. W. J. Lee, J.-Y. Shim, and B. T. Zhu, "Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids, "Molecular Pharmacology, vol. 68, no. 4, pp. 1018-1030, 2005.
74. P. L. Pedersen, "Tumor mitochondria and the bioenergetics of cancer cells., " Progress in Experimental Tumor Research, vol. 22, pp. 190-274, 1978.
75. O. Warburg, "Uber den Stoffwechsel derCarcinomzelle, " Naturwissenschaften, vol. 12, no. 50, pp. 1131-1137, 1924.
76. O. Warburg, "On the origin of cancer cells, " Science, vol. 123, no. 3191, pp. 309-314, 1956.
77. R. Covian and R. S. Balaban, "Cardiac mitochondrial matrix and respiratory complex protein phosphorylation, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 303, no. 8, pp. H940-H966, 2012.
78. G. Villani, M. Greco, S. Papa, and G. Attardi, "Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types, " Journal of Biological Chemistry, vol. 273, no. 48, pp. 31829-31836, 1999.
79. W. S. Kunz, A. Kudin, S. Vielhaber, C. E. Elger, G. Attardii, and G. Villani, "Flux control of cytochrome c oxidase in human skeletalmuscle, " Journal of Biological Chemistry, vol. 275, no. 36, pp. 27741-27745, 2000.
80. M. Hüttemann, I. Lee, L. Samavati, H. Yu, and J.W. Doan, "Regulation of mitochondrial oxidative phosphorylation through cell signaling, " Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1773, no. 12, pp. 1701-1720, 2007.
81. M. Hüttemann, I. Lee, A. Pecinova, P. Pecina, K. Przyklenk, and J. W. Doan, "Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease, " Journal of Bioenergetics and Biomembranes, vol. 40, no. 5, pp. 445-456, 2008.
82. S. K. Prabu, H. K. An and atheerthavarada, H. Raza, S. Srinivasan, J. F. Spear, and N. G. Avadhani, "Protein kinase A-mediated phosphorylationmodulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury, " Journal of Biological Chemistry, vol. 281, no. 4, pp. 2061-2070, 2006.
83. D. Guo, T. Nguyen, M. Ogbi et al., "Protein kinase C-coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 4, pp. H2219-H2230, 2007.
84. Z. X. Chen and S. Pervaiz, "Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2, " Cell Death and Differentiation, vol. 17, no. 3, pp. 408-420, 2010.
85. T. H. S and erson, G. Mahapatra, P. Pecina et al., "Cytochrome c is tyrosine 97 phosphorylated by neuroprotective insulin treatment, " PLoS ONE, vol. 8, no. 11, Article ID e78627, 2013.
86. K. C. Hess, J. Liu, G. Manfredi et al., "A mitochondrial CO2-Adenylyl cyclase-cAMP signalosome controls yeast normoxic cytochrome c oxidase activity, " The FASEB Journal, vol. 28, no. 10, pp. 4369-4380, 2014.
87. M. Hüttemann, I. Lee, L. I. Grossman, J. W. Doan, and T. H. S and erson, "Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease, " Advances in Experimental Medicine and Biology, vol. 748, pp. 237-264, 2012.
88. M. Hüttemann, S. Helling, T. H. S and erson et al., "Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/ reperfusion injury and inflammation, " Biochimica et Biophysica Acta, vol. 1817, no. 4, pp. 598-609, 2012.
89. J. L. Boerner, M. L. Demory, C. Silva, and S. J. Parsons, "Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II, " Molecular and Cellular Biology, vol. 24, no. 16, pp. 7059-7071, 2004.
90. M. L. Demory, J. L. Boerner, R. Davidson et al., "Epidermal growth factor receptor translocation to the mitochondria: regulation and effect, " Journal of Biological Chemistry, vol. 284, no. 52, pp. 36592-36604, 2009.
91. Y. Ding, Z. Liu, S. Desai et al., "Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism, " Nature Communications, vol. 3, article 1271, 2012.
92. M. Hüttemann, I. Lee, and M. H. Malek, "(-)-epicatechin maintains endurance training adaptation in mice after 14 days of detraining, " The FASEB Journal, vol. 26, no. 4, pp. 1413-1422, 2012.
93. W.-Y. Zhang, H.-Q. Liu, K.-Q. Xie et al., "Procyanidin dimer B2 [epicatechin-(4-8)-epicatechin] suppresses the expression of cyclooxygenase-2 in endotoxin-Treated monocytic cells, " Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 508-515, 2006.
94. T. Marchbank, A. Mahmood, and R. J. Playford, "Pancreatic secretory trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2, " American Journal of Physiology-Renal Physiology, vol. 305, no. 3, pp. F382-F389, 2013.
95. A. B. Granado-Serrano, M. A. Martín, G. Haegeman, L. Goya, L. Bravo, and S. Ramos, "Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells, " British Journal of Nutrition, vol. 103, no. 2, pp. 168-179, 2010.
96. I. Ramirez-Sanchez, H. Aguilar, G. Ceballos, and F. Villarreal, "(-)-Epicatechin-induced calcium independent eNOS activation: roles ofHSP90 and AKT, "Molecular and Cellular Biochemistry, vol. 370, no. 1-2, pp. 141-150, 2012.
97. I. Ramirez-Sanchez, L. Nogueira, A. Moreno et al., "Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: Additive effects with exercise, " Journal of Cardiovascular Pharmacology, vol. 60, no. 5, pp. 429-438, 2012.
98. M. Hüttemann, I. Lee, G. A. Perkins, S. L. Britton, L. G. Koch, and M. H. Malek, "(-)-epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity, " Clinical Science, vol. 124, no. 11, pp. 663-674, 2013.
99. L. Nogueira, I. Ramirez-Sanchez, G. A. Perkins et al., "(-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle, " Journal of Physiology, vol. 589, no. 18, pp. 4615-4631, 2011.
100. A. Moreno-Ulloa, D. Romero-Perez, F. Villarreal, G. Ceballos, and I. Ramirez-Sanchez, "Cell membrane mediated (-)-epicatechin effects on upstream endothelial cell signaling: evidence for a surface receptor, " Bioorganic &Medicinal Chemistry Letters, vol. 24, no. 12, pp. 2749-2752, 2014.
101. M. Panneerselvam, Y. M. Tsutsumi, J. A. Bonds et al., "Dark chocolate receptors: Epicatechin-induced cardiac protection is dependent on-opioid receptor stimulation, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 299, no. 5, pp. H1604-H1609, 2010.
102. M. Panneerselvam, S. S. Ali, J. C. Finley et al., "Epicatechin regulation of mitochondrial structure and function is opioid receptor dependent, " Molecular Nutrition and Food Research, vol. 57, no. 6, pp. 1007-1014, 2013.
103. T. H. S and erson, C. A. Reynolds, R. Kumar, K. Przyklenk, and M. Hüttemann, "Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation, " Molecular Neurobiology, vol. 47, no. 1, pp. 9-23, 2013.
104. H. M. Honda, P. Korge, and J. N. Weiss, "Mitochondria and ischemia/reperfusion injury, " Annals of the New York Academy of Sciences, vol. 1047, pp. 248-258, 2005.
105. K. G. Yamazaki, A. Y. Andreyev, P. Ortiz-Vilchis et al., "Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function, " International Journal of Cardiology, vol. 175, no. 2, pp. 297-306, 2014.
106. P. S. M. Prince, "(-) epicatechin attenuates mitochondrial damage by enhancing mitochondrial multi-marker enzymes, Adenosine triphosphate and lowering calcium in isoproterenol induced myocardial infarcted rats, " Food and Chemical Toxicology, vol. 53, pp. 409-416, 2013.
107. C. C. Leonardo, M. Agrawal, N. Singh, J. R. Moore, S. Biswal, and S. Doré, "Oral administration of the flavanol (-)-epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway, " European Journal of Neuroscience, vol. 38, no. 11, pp. 3659-3668, 2013.